2m 2m 2m 2m 2m 2m 2m
ATYR PHARMA (ATYR)
NASDAQ
$0.52-$0.004 (-0.77%)
Price as of Jun 03, 2026 7:08 PM EDT- $53.2MMarket Cap
- -90.35%1-Year Change
- BiotechnologyIndustry
ATYR PHARMA (ATYR)
$0.52-$0.004 (-0.77%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 190,000 -19.15% | 235,000 -33.43% | 353,000 -96.60% | 10.4M -0.66% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 190,000 -19.15% | 235,000 -33.43% | 353,000 -96.60% | 10.4M -0.66% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -60.2M +10.75% | -54.4M +28.56% | -42.3M -1.20% | -42.8M +84.01% | |
Depreciation and Amortization Expense | 664,000 -6.21% | 708,000 +19.59% | 592,000 +155.17% | 232,000 -51.16% | |
Total Operating Expenses | 77.8M +14.19% | 68.1M +23.30% | 55.3M -2.67% | 56.8M +66.96% | |
Operating Profit | -77.6M +14.30% | -67.9M +23.66% | -54.9M +18.35% | -46.4M +36.42% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 3.5M -9.97% | 3.9M -13.93% | 4.5M +326.20% | 1.1M +345.80% | |
Income before Taxes | -77.6M +14.30% | -67.9M +23.66% | -54.9M +18.35% | -46.4M +36.42% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -74.1M +15.77% | -64.0M +27.06% | -50.4M +11.14% | -45.3M +34.26% | |
Net Income from Continuing Operations Applicable to Common | -74.1M +15.77% | -64.0M +27.06% | -50.4M +11.14% | -45.3M +34.26% | |
Basic EPS and Net Income | -0.80 -6.98% | -0.86 -8.51% | -0.94 -41.25% | -1.60 -9.60% | |
Diluted EPS and Net Income | -0.80 -6.98% | -0.86 -8.51% | -0.94 -41.25% | -1.60 -9.60% | |
Basic Weighted Average Shares | 93.0M +25.21% | 74.3M +38.53% | 53.6M +88.63% | 28.4M +48.94% | |
Diluted Weighted Average Shares | 93.0M +25.21% | 74.3M +38.53% | 53.6M +88.63% | 28.4M +48.94% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 10.7M -2.82% | 11.1M -50.96% | 22.5M +125.87% | 10.0M +327.27% | |
Short-Term Investments | 67.9M +11.26% | 61.1M -19.24% | 75.6M +34.64% | 56.2M -46.80% | |
Cash and Cash Equivalents and Short-Term Investments | 78.7M +9.10% | 72.1M -26.53% | 98.2M +48.41% | 66.1M -38.70% | |
Total Current Assets | 80.2M -2.10% | 82.0M -20.43% | 103.0M +27.35% | 80.9M -28.79% | |
Accumulated Depreciation | 4.8M +6.30% | 4.5M -1.71% | 4.6M -27.27% | 6.4M +3.20% | |
Property and Plant and Equipment and Net | 4.3M -12.10% | 4.8M -12.31% | 5.5M +80.81% | 3.1M +463.35% | |
Total Long-Term Assets | 148,000 +124.24% | 66,000 -49.62% | 131,000 -32.12% | 193,000 +22.15% | |
Total Assets | 93.0M -3.95% | 96.8M -19.75% | 120.7M +25.96% | 95.8M -17.09% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 15.1M +1.21% | 15.0M -8.83% | 16.4M +18.42% | 13.9M +130.53% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 10.3M -7.50% | 11.1M -9.68% | 12.3M +28.09% | 9.6M +2,320.35% | |
Total Liabilities | 25.5M -2.51% | 26.1M -9.19% | 28.8M +22.39% | 23.5M +266.48% | |
Retained Earnings | -606.2M +13.93% | -532.0M +13.68% | -468.0M +12.07% | -417.6M +12.18% | |
Total Stockholders Equity | 67.5M -3.63% | 70.0M -22.77% | 90.7M +26.86% | 71.5M -34.62% | |
Total Shares Outstanding | 98.0M +16.65% | 84.0M +32.79% | 63.3M +114.54% | 29.5M +6.14% | |
Cash Flow | |||||
Cash from Operating Activities | -62.0M -10.32% | -69.1M +108.06% | -33.2M -20.69% | -41.9M +26.64% | |
Capital Expenditures | 77,000 +18.46% | 65,000 -98.46% | 4.2M +156.86% | 1.6M +754.69% | |
Cash from Investing Activities | -5.1M -129.32% | 17.2M +185.62% | -20.1M -142.60% | 47.2M +151.60% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 66.0M +65.59% | 39.9M -39.81% | 66.2M +1,115.01% | 5.5M -95.05% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -40,856.32% +41.37% | -28,899.57% +85.76% | -15,557.79% +3,382.10% | -446.79% +37.33% | |
Return on Assets | -78.09% +32.63% | -58.88% +26.45% | -46.56% +8.51% | -42.91% -1.99% | |
Return on Equity | -107.81% +35.28% | -79.69% +28.20% | -62.16% +23.92% | -50.16% +4.69% | |
Revenue Growth | -19.15% -42.72% | -33.43% -65.40% | -96.60% +14,536.55% | -0.66% N/A | |
Current Ratio | 5.30 -3.26% | 5.48 -12.72% | 6.27 +7.54% | 5.83 -69.11% | |
Cash Ratio | 0.71 -3.98% | 0.74 -46.22% | 1.37 +90.74% | 0.72 +85.33% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow